A novel CCK2/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma – GRAN-T-MTC – a multicenter phase I study

Polish Archives of Internal Medicine ◽

10.20452/pamw.4387 ◽

2018 ◽

Cited By ~ 3

Author(s):

Paola Anna Erba ◽

Helmut Maecke ◽

Renata Mikołajczak ◽

Clemens Decristoforo ◽

Katja Zaletel ◽

...

Keyword(s):

Thyroid Carcinoma ◽

Phase I ◽

Medullary Thyroid Carcinoma ◽

Phase I Study ◽

Medullary Thyroid ◽

Gastrin Receptor ◽

Peptide Probe ◽

Diagnosis And Therapy ◽

Multicenter Phase ◽

Personalized Diagnosis

Download Full-text

Role of 188Re(V)DMSA in the diagnosis and therapy of medullary thyroid carcinoma

Nuclear Medicine Communications ◽

10.1097/00006231-199904000-00131 ◽

1999 ◽

Vol 20 (4) ◽

pp. 398

Author(s):

D. L. Learoyd ◽

P. J. Roach ◽

G. M. Snowdon ◽

K. Dadachova ◽

A. M. Moreau ◽

...

Keyword(s):

Thyroid Carcinoma ◽

Medullary Thyroid Carcinoma ◽

Medullary Thyroid ◽

Diagnosis And Therapy

Download Full-text

Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma

European Journal of Nuclear Medicine and Molecular Imaging ◽

10.1007/s00259-006-0157-8 ◽

2006 ◽

Vol 33 (11) ◽

pp. 1273-1279 ◽

Cited By ~ 63

Author(s):

Martin Gotthardt ◽

Martin P. Béhé ◽

Daniela Beuter ◽

Anke Battmann ◽

Artur Bauhofer ◽

...

Keyword(s):

Thyroid Carcinoma ◽

Medullary Thyroid Carcinoma ◽

Medullary Thyroid ◽

Tumour Detection ◽

Gastrin Receptor ◽

Receptor Scintigraphy

Download Full-text

Truncated minigastrin analogues with improved metabolic stability for diagnosis and therapy of medullary thyroid carcinoma

Nuclear Medicine and Biology ◽

10.1016/j.nucmedbio.2010.04.158 ◽

2010 ◽

Vol 37 (6) ◽

pp. 722-723

Keyword(s):

Thyroid Carcinoma ◽

Medullary Thyroid Carcinoma ◽

Metabolic Stability ◽

Medullary Thyroid ◽

Diagnosis And Therapy

Download Full-text

Phase I/II trial of131I-MN-14 F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma

Cancer ◽

10.1002/(sici)1097-0142(19990415)85:8<1828::aid-cncr25>3.0.co;2-h ◽

1999 ◽

Vol 85 (8) ◽

pp. 1828-1842 ◽

Cited By ~ 58

Author(s):

Malik E. Juweid ◽

George Hajjar ◽

Lawrence C. Swayne ◽

Robert M. Sharkey ◽

Samer Suleiman ◽

...

Keyword(s):

Monoclonal Antibody ◽

Thyroid Carcinoma ◽

Phase I ◽

Carcinoembryonic Antigen ◽

Medullary Thyroid Carcinoma ◽

Medullary Thyroid

Download Full-text

Diagnosis and therapy of sporadic and familial medullary thyroid carcinoma

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s004320000173 ◽

2001 ◽

Vol 127 (3) ◽

pp. 156-165 ◽

Cited By ~ 41

Author(s):

Oliver Gimm ◽

Thomas Sutter ◽

Henning Dralle

Keyword(s):

Thyroid Carcinoma ◽

Medullary Thyroid Carcinoma ◽

Medullary Thyroid ◽

Familial Medullary Thyroid Carcinoma ◽

Diagnosis And Therapy

Download Full-text

New Radionuclide Tracers for the Diagnosis and Therapy of Medullary Thyroid Carcinoma

Clinical Nuclear Medicine ◽

10.1097/00003072-198803000-00003 ◽

1988 ◽

Vol 13 (3) ◽

pp. 159-165 ◽

Cited By ~ 41

Author(s):

C A HOEFNAGEL ◽

C C DELPRAT ◽

D ZANIN ◽

J B van der SCHOOT

Keyword(s):

Thyroid Carcinoma ◽

Medullary Thyroid Carcinoma ◽

Medullary Thyroid ◽

Diagnosis And Therapy ◽

Radionuclide Tracers

Download Full-text

Development of cholecystokinin-B/gastrin-receptor binding peptides for diagnosis and therapy: Results of a clinical phase-I/II study for the staging of known and occult metastatic medullary thyroid cancer

Nuclear Medicine Communications ◽

10.1097/00006231-200006000-00023 ◽

2000 ◽

Vol 21 (6) ◽

pp. 564-565 ◽

Cited By ~ 3

Author(s):

T. M. Behr ◽

M. Béhé ◽

C. Angerstein ◽

S. Gratz ◽

M. Hüfner ◽

...

Keyword(s):

Thyroid Cancer ◽

Phase I ◽

Receptor Binding ◽

Medullary Thyroid Cancer ◽

Medullary Thyroid ◽

Gastrin Receptor ◽

Clinical Phase ◽

Diagnosis And Therapy ◽

Binding Peptides

Download Full-text

A Multicenter Phase 2 Trial of Pazopanib in Metastatic and Progressive Medullary Thyroid Carcinoma: MC057H

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2013-3713 ◽

2014 ◽

Vol 99 (5) ◽

pp. 1687-1693 ◽

Cited By ~ 66

Author(s):

Keith C. Bible ◽

Vera J. Suman ◽

Julian R. Molina ◽

Robert C. Smallridge ◽

William J. Maples ◽

...

Keyword(s):

Thyroid Carcinoma ◽

Medullary Thyroid Carcinoma ◽

Phase 2 ◽

Medullary Thyroid ◽

Phase 2 Trial ◽

Multicenter Phase

Download Full-text

Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinoma

Biomedicine & Pharmacotherapy ◽

10.1016/j.biopha.2007.07.011 ◽

2008 ◽

Vol 62 (3) ◽

pp. 139-146 ◽

Cited By ~ 33

Author(s):

Vittoria Rufini ◽

Paola Castaldi ◽

Giorgio Treglia ◽

Germano Perotti ◽

Milton D. Gross ◽

...

Keyword(s):

Nuclear Medicine ◽

Thyroid Carcinoma ◽

Medullary Thyroid Carcinoma ◽

Medullary Thyroid ◽

Diagnosis And Therapy ◽

Nuclear Medicine Procedures

Download Full-text

Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in medullary thyroid carcinoma patients

European Journal of Pharmaceutical Sciences ◽

10.1016/j.ejps.2016.05.011 ◽

2016 ◽

Vol 91 ◽

pp. 236-242 ◽

Cited By ~ 17

Author(s):

Theodosia Maina ◽

Mark W. Konijnenberg ◽

Petra KolencPeitl ◽

Piotr Garnuszek ◽

Berthold A. Nock ◽

...

Keyword(s):

Clinical Trial ◽

Thyroid Carcinoma ◽

Phase I ◽

Medullary Thyroid Carcinoma ◽

Radiation Dosimetry ◽

Regulatory Approval ◽

Phase I Clinical Trial ◽

Medullary Thyroid ◽

Preclinical Pharmacokinetics ◽

Toxicity Studies

Download Full-text